Inactive and active state structures template selective tools for the human 5-HT5A receptor

被引:0
|
作者
Shicheng Zhang
He Chen
Chengwei Zhang
Ying Yang
Petr Popov
Jing Liu
Brian E. Krumm
Can Cao
Kuglae Kim
Yan Xiong
Vsevolod Katritch
Brian K. Shoichet
Jian Jin
Jonathan F. Fay
Bryan L. Roth
机构
[1] University of North Carolina at Chapel Hill,Department of Pharmacology, School of Medicine
[2] Tisch Cancer Institute,Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience
[3] Icahn School of Medicine at Mount Sinai,Department of Pharmaceutical Sciences
[4] University of California San Francisco,Departments of Quantitative and Computational Biology and Chemistry, Bridge Institute, USC Michelson Center for Convergent Biosciences
[5] School of Medicine,Department of Biochemistry and Biophysics
[6] iMolecule,undefined
[7] Skolkovo Institute of Science and Technology,undefined
[8] University of Southern California,undefined
[9] University of North Carolina at Chapel Hill School of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Serotonin receptors are important targets for established therapeutics and drug development as they are expressed throughout the human body and play key roles in cell signaling. There are 12 serotonergic G protein-coupled receptor members encoded in the human genome, of which the 5-hydroxytryptamine (5-HT)5A receptor (5-HT5AR) is the least understood and lacks selective tool compounds. Here, we report four high-resolution (2.73–2.80 Å) structures of human 5-HT5ARs, including an inactive state structure bound to an antagonist AS2674723 by crystallization and active state structures bound to a partial agonist lisuride and two full agonists, 5-carboxamidotryptamine (5-CT) and methylergometrine, by cryo-EM. Leveraging the new structures, we developed a highly selective and potent antagonist for 5-HT5AR. Collectively, these findings both enhance our understanding of this enigmatic receptor and provide a roadmap for structure-based drug discovery for 5-HT5AR.
引用
收藏
页码:677 / 687
页数:10
相关论文
共 50 条
  • [31] QSAR-BASED MODELLING OF CYCLIC GUANIDINES AS 5-HT5A RECEPTOR ANTAGONISTS
    Srivastava, A. K.
    Nath, A.
    Chaurasia, S.
    Pandey, A.
    OXIDATION COMMUNICATIONS, 2011, 34 (01): : 117 - 127
  • [32] Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor
    Muntasir, Habib Abul
    Bhuiyan, Mohiuddin Ahmed
    Ishiguro, Masaji
    Ozaki, Masanobu
    Nagatomo, Takafumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 102 (02) : 189 - 195
  • [33] Association of a 5-HT5A receptor polymorphism, Pro15Ser, to schizophrenia
    N Iwata
    N Ozaki
    T Inada
    D Goldman
    Molecular Psychiatry, 2001, 6 : 217 - 219
  • [34] The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells
    Francken, BJB
    Jurzak, M
    Vanhauwe, JFM
    Luyten, WHML
    Leysen, JE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 361 (2-3) : 299 - 309
  • [35] Functional mode of action of ASP5736, a selective 5-HT5A receptor antagonist for treatment of cognitive dysfunction in schizophrenia
    Svensson, T. H.
    Yamazaki, M.
    Yamamoto, N.
    Yarimizu, J.
    Okabe, M.
    Moriyama, A.
    Furutani, M.
    Marcus, M.
    Harada, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S414 - S415
  • [36] Functional coupling of a recombinant human 5-HT5A receptor to G-proteins in HEK-293 cells
    Hurley, PT
    McMahon, RA
    Fanning, P
    O'Boyle, KM
    Rogers, M
    Martin, F
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (06) : 1238 - 1244
  • [37] Family-based association studies between 5-HT5A receptor gene and schizophrenia
    Dubertret, C
    Hanoun, N
    Adès, J
    Hamon, M
    Gorwood, P
    JOURNAL OF PSYCHIATRIC RESEARCH, 2004, 38 (04) : 371 - 376
  • [38] Genetic variation in the 5-HT5A receptor gene in patients with bipolar disorder and major depression
    Arias, B
    Collier, DA
    Gastó, C
    Pintor, L
    Gutiérrez, B
    Vallès, V
    Fañanás, L
    NEUROSCIENCE LETTERS, 2001, 303 (02) : 111 - 114
  • [39] Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor
    Kaplan, Anat Levit
    Strachan, Ryan T.
    Braz, Joao M.
    Craik, Veronica
    Slocum, Samuel
    Mangano, Thomas
    Amabo, Vanessa
    O'Donnell, Henry
    Lak, Parnian
    Basbaum, Allan, I
    Roth, Bryan L.
    Shoichet, Brian K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (05) : 4201 - 4217
  • [40] An association of a 5-HT5A receptor polymorphism, Pro15Ser, to Japanese schizophrenia
    Iwata, N
    Ozaki, N
    Inada, T
    Goldman, D
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 132S - 132S